Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q2 2025 Earnings Call Transcript August 5, 2025
Supernus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.91, expectations were $0.47.
Operator: Good day, and thank you for standing by. Welcome to the Supernus Pharmaceuticals Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to turn the conference over to your first...
